Management tracks

Rainer Boehm is retiring as chief commercial and medical affairs officer at the Novartis Pharma AG division of Novartis AG (NYSE:NVS; SIX:NOVN). Dhaval Patel is also retiring as European head of Novartis Institutes for BioMedical Research (NIBR).

The Buck Institute for Research on Aging named Edward Lanphier president and CEO, replacing Brian Kennedy. Lanphier was president and CEO at Sangamo BioSciences Inc. (NASDAQ:SGMO). Kennedy will continue to lead geroscience research at Buck. ...